P
US8389682B2ActiveUtilityPatentIndex 29

Inhibiting Staphylococcus epidermidis infections

Assignee: ARRECUBIETA CARLOSPriority: Jan 16, 2007Filed: Jan 16, 2008Granted: Mar 5, 2013
Est. expiryJan 16, 2027(~0.5 yrs left)· nominal 20-yr term from priority
Inventors:ARRECUBIETA CARLOSLEE MEI-HOLOWY FRANKLIN D
A61K 38/00A61P 31/04C07K 14/31A61K 2039/505
29
PatentIndex Score
1
Cited by
24
References
5
Claims

Abstract

The invention relates to Staphylococcus epidermidis peptides, antibodies and nucleic acids that can inhibit Staphylococcus epidermidis infection of a mammalian subject and colonization of a medical device in the mammal.

Claims

exact text as granted — not AI-modified
1. An isolated  Staphylococcus epidermidis  SdrF peptide consisting of any of SEQ ID NOs: 3-9, or 31. 
     
     
       2. A composition comprising a pharmaceutically acceptable carrier and the peptide of  claim 1 . 
     
     
       3. A method of treating or inhibiting  Staphylococcus epidermidis  infection in a mammal comprising administering to the mammal a composition comprising an isolated  Staphylococcus epidermidis  SdrF peptide consisting of any of SEQ ID NO:3-9, 31, or a combination thereof to thereby treat or inhibit  Staphylococcus epidermidis  infection in a mammal. 
     
     
       4. The method of  claim 3 , wherein the method inhibits  Staphylococcus epidermidis  colonization of a medical device in the mammal. 
     
     
       5. A composition comprising an isolated  Staphylococcus epidermidis  SdrF peptide consisting of any of SEQ ID NOS:3-9, 31, or a combination thereof.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.